Express Scripts (ESRX) – General News
-
Cigna boosts 2018 forecast after third quarter earnings beat
-
Cigna deal gets antitrust nod, positive sign for CVS/Aetna
-
Cigna, Express Scripts shareholders approve $52 billion deal
-
Express Scripts staking out million-dollar gene therapies
-
Glenview backs Cigna-Express Scripts deal after Icahn criticism
-
Icahn urges Cigna shareholders to vote against Express Scripts deal
-
Icahn, with sizable stake in Cigna, to oppose Express Scripts acquisition: WSJ
-
U.S. antitrust official says worries over limiting vertical deals 'misplaced'
-
Lawsuit against Express Scripts over Anthem ties dismissed
-
Express Scripts targets Amgen, Lilly migraine drugs in pricing shift
-
Glenview's Robbins says talk of Amazon's entering pharma is overblown
-
UnitedHealth earnings ease investor worries over flu season, stock up
-
Express Scripts CEO sees Amazon as a potential partner: CNBC
-
Anthem top executive Swedish to become adviser, Boudreaux named CEO
-
CVS (CVS), Related Stocks Decline as Amazon (AMZN) Said to Receive Wholesale Pharmacy Licenses in at Least 12 States
-
Mylan hit with new class action lawsuit over EpiPen pricing
-
Obamacare Subsidies Upheld by U.S. Supreme Court (UNH) (HCA) (CYH)
-
StreetInsider.com After-Hours Movers 04/23
-
The Dow Lost 4 Points, Nasdaq Loses 22
-
StreetInsider.com Pre-Open Movers 12/18
-
Largest Net $ Movers of Note 09/21
-
StreetInsider.com Trading Radar 07/26
Back to ESRX Stock Lookup